انتشارات:

• FarzanehRahvar¹, MahdiehSalimi¹*, Hossein Mozdarani²Plasma GBP2 promoter methylation is associated with advanced stages in breast cancer, Genetics and Molecular Biology, 2020, accepted. Under press.

· NarjesBakhtari, Hossein Mozdarani, MahdiehSalimi, Ramesh Omranipour, Association study of miR-22 and miR-335 expression levels and G2 assay related inherent radiosensitivity in peripheral blood of ductal carcinoma breast cancer patients, neo_2020_200225N185

· FatemehPakniyatHassan Ali NedaieHossein MozdaraniAziz MahmoudzadehMahdiehSalimi, Enhanced Response of Radioresistant Carcinoma Cell Line to Heterogeneous Dose Distribution of Grid; The Role of High-Dose Bystander Effect.Int J RadiatBiol 2020 Oct 19:1-45. Epub 2020 Oct 19.

• Heidarizadi A, Salimi M, Mozdarani H. Study of DOK4 gene expression and promoter methylation in sporadic breast cancer. Neoplasma. 2020 Jul;67(4):916-921. doi: 10.4149/neo_2020_190811N747. Epub 2020 May 6. PMID: 32386480.

• Heidarizadi  A, Salimi M, Mozdarani H. 2020. Study of ELF5 expression and promoter methylation status in Breast Cancer Patients, Ilam University of medical sciences, accepted, under press.

• Salimi M, Afzali F, Unearthing Regulatory Axes of Breast Cancer circRNAs Networks to Find Novel Targets and Fathom Pivotal Mechanisms, Interdisciplinary Sciences2019 Dec;11(4):711-722. doi: 10.1007/s12539-019-00339-6.

·  ZangenehM; Nedaei H A,  MozdaraniH;  MahmoudzadehA; KharraziSh; Salimi M, Enhanced cytotoxic and genotoxic effects of gadolinium-doped ZnO nanoparticles on irradiated lung cancer cells at megavoltage radiation energies, Materials Science and EngineeringVolume 103, October 2019, 109739

• ZangenehM; Nedaei H A, MozdaraniH; MahmoudzadehA; KharraziSh; Salimi M, The role and mechanisms of zinc oxide nanoparticles in the improvement of the radiosensitivity of lung cancer cells in clinically relevant megavoltage radiation energies in-vitro, Nanomedicine journal, DOI: 10.22038/nmj.2019.13128, Articles in Press, Corrected Proof , Available Online from 19 May 2019.
• Salimi M, RastegarpouyaniSh ,E74-like Factor 5 Promoter Methylation in Circulating Tumor DNA as a New Possible Prognostic Marker in Breast Cancer Patients, APJCP, 2019, accepted.
• Seyedimoghadam A., Salimi M, Mozdarani H., Ranji M., Expression profilestudy of the panel of miRNAs (miR-21-5p, miR-221/222, miR-17-5p, miR-106b, miR-93-5p) in tumors and trace it in peripheral blood as possible breast cancer related biomarkers, Genes, 2018, under revision.
• Rahvar F, Salimi M*, Mozdarani H, Higher frequency of Guanylate binding protein 2 promoter methylation in plasma DNA of breast cancer patients, APJCO, 2018, under revision.

• Sheikhhosseini M, Salimi M, MozdaraniH , A-Kinase Anchor Protein 4 (AKAP4), a cancer testis antigen, may consider as potential early diagnostic breast cancer markerdetectable in blood, Pathology Oncology Research, 2018, under revision.
• Salimi M, Sedaghati S.,  Study of miR888  expression levels in breast cancer tumors and trace it in plasma as a circulating early detection biomarker, cancer investigation, 2018, under revision.

• Salimi M, Sedaghati S., Integrity and quantity evaluation of plasma cell-free DNA in triple negative breast cancer, AJMB, 2018, accepted, under press.

• Salimi M, SarrafzadehZargar S. Insulin Receptor Substrate 2 mRNA Expression in Urinary Sediment Cells as a Diagnostic Marker of Nephropathy in Diabetic Patients.Iran J Kidney Dis. 2018 May; 12(3):142-149.

• SalimiM,  EskandariE, Association of elevated peripheral blood micronucleus frequency and Bmi-1 mRNA expression with metastasis in Iranian breast cancer patient, Asian pacific journal of cancer prevention, 2018 , 19 (10), 2723-2730.

• Salimi M, 2018 Comparative study of chemo-sensitivity expressed as micronuclei in lymphocytes of breast cancer patients, their unaffected first degree relatives and normal controls as a possible prognostic marker, IJRR, 16(1), 85-93.

• Eskandari  E., Salimi M.,Mahjoubi F., Up-regulation of Bax-interacting factor-1 in Iranian Colorectal Cancer Patients, Basic and Clinical Cancer Reseearch,   Vol 10 No 2 (2018)

• ZonoziF, Mozdarani H^, , SalimiM, MozdaraniS , FallahiP, MozdaraniS, HeidariZ  High frequency of microdeletion in TTY2 gene family in peripheral blood leukocytes of non-obstructive azoospermia patients, AIMS Genetics, 2017, 4(4): 202-212. doi: 10.3934/genet.2017.4.202.

• MozdaraniH ,SalimiM., BakhtariN. Inherent radiosensitivity and its impact on breast cancer chemo-radiotherapy Int J Radiat Res 2017, 15(4): 325-341.

• Salimi M, 2018 Comparison of a radiomimetic agent sensitivity in breast cancer patients, their unaffected first degree relatives and normal control as a representor of genomic instability and possible prognostic factor, IJRR, under publish.

• Salimi M, Broumand B, Mozdarani H. 2016 Association of elevated frequency of micronuclei in peripheral blood lymphocytes of type 2 diabetes patients with nephropathy complications.Mutagenesis.pii: gew029.

• Khazaie N, Massumi M, Wee P, Salimi M, Mohammadnia A, Yaqubi M. 2016, Involvement of PolycombRepressiveComplex2 in Maturation of InducedPluripotentStemCells during Reprogramming of Mouse and HumanFibroblasts. PLoS One. Mar 3;11(3):e0150518.

• Mohammadi K, Salimi M, Angaji AH, Mahjoubi F, Majidizadeh T. 2016. BIf-1 relative gene expression study in breast cancer tumor and normal adjacent tissues using Real-Time PCR, Ilam University of medical sciences, accepted, under press.

• Shirani Sh., Mozdarani H., Mahmoodzadeh A., Salimi M. (2015) Radio-adaptive response of peripheral blood lymphocytes following bystander effects induced by preirradiated CHO-K1 cells using the micronucleus assay, Int. J. R. R., April 2015, 13(2):151-156.

• • Salimi M.Mozdarani H. (2015) Different aspects of CBMN assay as a comprehensive measurement tool for chromosomal instability focus on radiobiodosimetery. A review article, IJRR. 2015, 13(2):101-126.

• • Salimi M., Mozdarani H., Nazari  E. (2014)Cytogenetic alterations in preimplantation mice embryos following paternal gamma-irradiation expressed as numerical chromosomal abnormalities and micronuclei: Comparison of two methods for reproductive toxicity screening ,Avicenna journal of Medical Biotechnology;6(3):130-9.

• • Salimi M.,Mozdarani H. (2014) γ-H2AX as a protein biomarker for radiation exposure response in ductal carcinoma breast tumors: Experimental evidence and literature Review. IJRR.,12(1):1-11.

• • Salimi M., Mozdarani H., Majidzadeh-A K (2012) Efficacy of Primed In Situ labeling (PRINS) in determination of HER-2 gene amplification and CEN-17 status in FFPE breast cancer tissues. Asian Pacific Journal of Cancer Prevention (APJCP), 13 No 1/2.

• • Salimi M,Mozdarani H., Majidzadeh-A K (2012)  Expression pattern of ATM and cyclin D1 in ductal carcinoma, normal adjacent and normal breast tissues of Iranian breast cancer patients. Med Oncol. 29(3):1502-9.

• • Salimi M., Mozdarani H. (2008)  Reduction of transgenerational radiation induced genetic damages observed as numerical chromosomal abnormalities in preimplantation embryos by vitamin E. Nukleonika, 53 (4) 137-143.

• • Mozdarani H., Salimi M., Froughizadeh M. (2008) Effect of cimetidine and famotidine on survival of lethally gamma irradiated mice. Iran J Radiat Res., 5 (4): 187-194.

• • Mozdarani H., Salimi M. (2006) Numerical chromosome abnormalities in 8- cell embryos generated from gamma irradiated male mice in the absence and presence of vitamin E. Int J Radiat Biol., 82 (11) 817-822.

• • Salimi M., Mozdarani H. (2006) Effect of vitamin E on preovulatory stage irradiated female mouse expressed as chromosomal abnormalities in generated embryos. Iran J Radiat Res., 4 (1): 54-40.